Search results
5 days ago · July 2, 2024. The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted with hope, disappointment ...
- Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and ...
The F.D.A. approved a new drug for early Alzheimer’s, the...
- Leqembi and Alzheimer’s: What to Know About the New Drug, Treatment and ...
3 days ago · The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, clearing the way for the third addition to a new class of drugs aimed at slowing the brain's...
4 days ago · The potential to complete the treatment after a limited course of therapy, Lilly said, could lower out-of-pocket costs. Kisunla otherwise costs more than Leqembi, which runs about $26,500 per year.
5 days ago · The U.S. Food and Drug Administration has approved Kisunla (donanemab-azbt) injection for the treatment of Alzheimer’s disease. Treatment with Kisunla should be initiated in patients with mild ...
Jun 10, 2024 · The F.D.A. approved a new drug for early Alzheimer’s, the latest in a novel class of treatments that has been greeted with hope, disappointment and skepticism.
Jun 27, 2024 · A ketamine-containing tablet could be a convenient alternative to intravenous treatments, with fewer unpleasant side effects.
Jun 20, 2024 · Scientists may be a step closer to that reality, thanks to new research that has identified six subtypes — or “biotypes” — of major depression via brain imaging combined with machine ...
